Literature DB >> 3490987

Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20).

V Barak, A J Treves, P Yanai, M Halperin, D Wasserman, S Biran, S Braun.   

Abstract

Culture supernatants from a myelomonocytic cell line (M20) were found to inhibit interleukin 1 (IL 1) activity in vitro. The factor, isolated from these supernatants, inhibited augmentation of phytohemagglutinin response of mouse thymus cells induced by IL 1 derived from several established cell lines. Various IL 1-dependent activities such as lymphocyte and fibroblast proliferation in vitro were also inhibited by the factor. The factor did not inhibit IL 2-induced or other proliferative responses not related to IL 1. Preliminary biochemical characterization of the factor indicated that the activity resides in a protein with a molecular mass of 52 kDa.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490987     DOI: 10.1002/eji.1830161122

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

3.  A novel urinary sialoglycoprotein as the inhibitor of interleukin-1.

Authors:  S Kabir; H Wigzell
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

4.  A human urine-derived interleukin 1 inhibitor. Homology with deoxyribonuclease I.

Authors:  D L Rosenstreich; J H Tu; P R Kinkade; I Maurer-Fogy; J Kahn; R W Barton; P R Farina
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.